Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-04-007758
Filing Date
2004-03-12
Accepted
2004-03-12 17:26:53
Documents
10
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2122057z10-k.htm 10-K 710052
3 EXHIBIT 10.69 a2122057zex-10_69.txt EX-10.69 325057
4 EXHIBIT 10.70 a2122057zex-10_70.txt EX-10.70 118508
5 EXHIBIT 14.1 a2122057zex-14_1.txt EX-14.1 21080
6 EXHIBIT 23.1 a2122057zex-23_1.txt EX-23.1 682
7 EXHIBIT 31.1 a2122057zex-31_1.htm EX-31.1 5582
8 EXHIBIT 31.2 a2122057zex-31_2.htm EX-31.2 5594
9 EXHIBIT 32.1 a2122057zex-32_1.htm EX-32.1 2614
10 EXHIBIT 32.2 a2122057zex-32_2.htm EX-32.2 2626
11 EXHIBIT 99.4 a2122057zex-99_4.txt EX-99.4 18535
  Complete submission text file 0001047469-04-007758.txt   1212884
Mailing Address 24 EMILY ST CAMBRIDGE MA 02139
Business Address 65 HAYDEN AVENUE LEXINGTON MA 02421 781-860-8660
CUBIST PHARMACEUTICALS INC (Filer) CIK: 0000912183 (see all company filings)

EIN.: 223192085 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21379 | Film No.: 04667089
SIC: 2834 Pharmaceutical Preparations